stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Tyra Biosciences IncTYRA
$21.240.63%-0.135

Tyra Biosciences Inc (TYRA)

Date: 2026-11-04 16:00O: 21.91H: 21.91L: 20.78C: 21.31Vol: 289.7k
Schlusskurs vom Vortag:
$21.37
Offen:
$21.91
24-Stunden-Volumen:
197,447
Relatives Volumen:
0.33
Marktkapitalisierung:
$1.46B
Einnahmen:
-
Nettoeinkommen (Verlust:
-$131.11M
KGV:
-
EPS:
-$2.17
Netto-Cashflow:
-$102.47M
1W Leistung:
-2.37%
1M Leistung:
+3.94%
6M Leistung:
-39.57%
1Y Leistung:
+41.57%
1-Tages-Spanne:
$20.78$21.91
1-Wochen-Bereich:
$20.32$22.37
52-Wochen-Spanne:
$13.35$40.65

Tyra Biosciences Inc Aktie (TYRA) Unternehmensprofil

Firmenname
Tyra Biosciences Inc
Telefon
(619) 728-4760
Adresse
2656 STATE STREET, CARLSBAD, USA
Mitarbeiter
87
X
-
Nächster Verdiensttermin
2026-11-04
Neueste SEC-Einreichungen
SEC
TYRA-Diskussionen auf X
X

 

Marktkapitalisierung

 

Umsatz

 

Nettogewinn

 

Free Cashflow

 

ENV

 

Tyra Biosciences Inc Aktie (TYRA) Hochstufungen & Herabstufungen

DatumAktionAnalytikerRatingänderung
2026-05-19EingeleitetWolfe ResearchPeer Perform
2026-04-15EingeleitetGuggenheimBuy
2026-04-06EingeleitetCanaccord GenuityBuy
2026-02-24EingeleitetCantor FitzgeraldOverweight

Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)

ZeitraumTrendFY 2025FY 2024FY 2023FY 2022FY 2021
Enddatum des Zeitraums2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)--0.000.000.00
Research and development USD (M)102.9380.0862.5243.0120.64
Operating expenses USD (M)132.76104.1879.9558.9326.29
Operating income USD (M)-132.76-104.18-79.95-58.93-26.29
Income before tax USD (M)---69.13-55.32-26.29
Income tax expense USD (M)0.000.000.000.000.00
Net income USD (M)-119.95-86.48-69.13-55.33-26.29
Basic EPS USD/shares-2.01-1.51-1.62-1.32-
Diluted EPS USD/shares-2.01-1.51-1.62-1.32-
Basic weighted shares shares (M)59.6057.2242.7041.88-
Diluted weighted shares shares (M)59.6057.2242.7041.88-

Tyra Biosciences Inc-Aktie (TYRA) Insiderhandel

  • Verjee RehanSep 09 '26
    Director
    Transaktion
    Buy
    Kosten
    $20.58
    #Aktien
    972
    Wert ($)
    20,000
    #Aktien Gesamt
    972
  • Shareholder
    Transaktion
    Proposed Sale
    Kosten
    $30.94
    #Aktien
    308,379
    Wert ($)
    9,541,246
    #Aktien Gesamt
    0
  • Shareholder
    Transaktion
    Proposed Sale
    Kosten
    $33.41
    #Aktien
    300,000
    Wert ($)
    10,023,000
    #Aktien Gesamt
    0
  • Daniel BensenMay 12 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $34.25
    #Aktien
    8,000
    Wert ($)
    274,000
    #Aktien Gesamt
    0
  • Daniel BensenApr 13 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $35.62
    #Aktien
    8,000
    Wert ($)
    285,000
    #Aktien Gesamt
    0
  • GILLA KAPLANMar 26 '26
    Director
    Transaktion
    Proposed Sale
    Kosten
    $37.75
    #Aktien
    53,172
    Wert ($)
    2,007,153
    #Aktien Gesamt
    0
  • GILLA KAPLANMar 25 '26
    Director
    Transaktion
    Proposed Sale
    Kosten
    $36.97
    #Aktien
    14,295
    Wert ($)
    528,506
    #Aktien Gesamt
    0
  • KAPLAN GILLAMar 25 '26
    Director
    Transaktion
    Option Exercise
    Kosten
    $2.25
    #Aktien
    14,295
    Wert ($)
    32,164
    #Aktien Gesamt
    42,526
  • KAPLAN GILLAMar 25 '26
    Director
    Transaktion
    Sale
    Kosten
    $36.97
    #Aktien
    14,295
    Wert ($)
    528,506
    #Aktien Gesamt
    28,231
  • Daniel BensenMar 12 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $35.38
    #Aktien
    8,000
    Wert ($)
    283,000
    #Aktien Gesamt
    0
InsiderhandelBeziehungDatumTransaktionKosten#AktienWert ($)#Aktien Gesamt
Verjee RehanDirectorSep 09 '26Buy$20.5897220,000972
NEXTECH VI ONCOLOGY SCSPShareholderJun 26 '26Proposed Sale$30.94308,3799,541,2460
NEXTECH VI ONCOLOGY SCSPShareholderJun 01 '26Proposed Sale$33.41300,00010,023,0000
Daniel BensenOfficerMay 12 '26Proposed Sale$34.258,000274,0000
Daniel BensenOfficerApr 13 '26Proposed Sale$35.628,000285,0000
GILLA KAPLANDirectorMar 26 '26Proposed Sale$37.7553,1722,007,1530
GILLA KAPLANDirectorMar 25 '26Proposed Sale$36.9714,295528,5060
KAPLAN GILLADirectorMar 25 '26Option Exercise$2.2514,29532,16442,526
KAPLAN GILLADirectorMar 25 '26Sale$36.9714,295528,50628,231
Daniel BensenOfficerMar 12 '26Proposed Sale$35.388,000283,0000

Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten

Oct 27, 2026
Oct 27, 2026
Oct 19, 2026
Oct 19, 2026
Oct 18, 2026
Oct 18, 2026
Oct 17, 2026
Oct 17, 2026
Oct 16, 2026
Oct 16, 2026
Oct 13, 2026
Oct 13, 2026
Oct 06, 2026
Oct 06, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 20, 2026
Sep 20, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 17, 2026
Sep 15, 2026
Sep 15, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 11, 2026
Sep 11, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026

Ähnlich wie TYRA